PhaseBio lands $2.8M NIH grant

A Chester County biopharmaceutical company received a $2.8 million grant from the National Institues of Health to support the clinical development of an experimental treatment for a rare type of high blood pressure that affects arteries in the lungs and in the heart. PhaseBio Pharmaceuticals Inc. of Malvern, Pa., which is specializing in therapies for the treatment of orphan diseases, received an NIH Fast Track Small Business Innovation Research grant for its new drug candidate targeting pulmonary…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news